Clinical use of H1-antihistamines
https://doi.org/10.21518/2079-701X-2016-4-74-81
Abstract
The article tells about the history of creation, questions of clinical pharmacology and the specific use of H1-antihistamines. The effectiveness and safety of I and II generation-drugs in patients with various diseases is demonstrated. Areas for further research are identified.
About the Author
A. V. Emelyanov
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
References
1. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт, 1998. С. 141-172.
2. Гущин И.С., О.М.Курбачева Аллергия и аллерген-специфическая иммунотерапия. М.: Фармарус Принт Медиа, 2010. 227с.
3. Simons FER. Advances in H1 -Antihistamines. N Engl J Med, 2004, 351: 2203-17.
4. Simons FER, Simons KJ. Histamine and ^-antihistamines: Celebrating a century of progress. J Allergy Clin Immunol, 2011, 128: 1139-1150.
5. Church MK, Church DS. Pharmacology of antihis-tamines. Indian J Dermatol, 2013, 58: 219-224.
6. Аллергология и иммунология. Национальное руководство. Краткое издание. Под ред. Р.М.Хаитова, Н.И.Ильиной. М.: Гзотар Медиа, 2012. С.88-95.
7. Горячкина Л.А., Передкова Е.В. Антигистаминные лекарствекнные средства. Клиническая аллергология и иммунология. Руководство для практикующих врачей. Под ред. ЛА. Горячкиной и К.П. Кашкина. М.: Миклош, 2009. С. 398-407.
8. Рациональная фармакотерапия аллергических заболеваний. Руководство для практикующих врачей. Под ред. Р.М. Хаитова, Н.И. Ильиной, Т.В. Латышевой, Л.В. Лусс. М.: Литтера, 2007. С. 24-31.
9. Church MK, Maurer M, Simons FER Risk of first generation ^-antihistamines: a GAL2EN position paper. Al1lergy, 2010, 65: 459-466.
10. Bousquet J, van Cauwenberge P, Khaltaev N et al. Allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol, 2001, 108(5): 147-334.
11. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN* and AllerGen**). Allergy, 2008, 63(suppl 86): 8-160.
12. Brozek JL, Bousquet J, Baena-Cagnani C et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. Allergy Clin Immunol, 2010, 126(3): 466-476.
13. Zuberbier T, Aberer W, Asero R et al. EAACI / GA2LEN/ EDF/ WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014, 69: 868-887.
14. Guschin I.S. Allergic inflammation and pharmacological management. М.: Farmarus Print, 1998. P. 141-172.
15. Gushchin I.S., O.M.Kurbacheva Allergy and allergen-specific immunotherapy. M.: Farmarus Print Media, 2010. 227p.
16. Allergology and Immunology. National Guidelines. Concise edition. Ed by R.M. Khaitov, N.I. Ilyina.-M: Geotar Media, 2012. P.88-95.
17. Goryachkina L.A., Peredkova E.V. Antihistamines. Clinical Allergy and Immunology. Guide for practitioners. Ed by L.A.Goryachkina and K.P. Kashkin. M.: Мiklosh, 2009. P. 398-407.
18. Rational pharmacotherapy of allergic diseases. Guide for practitioners. Ed. by R.M. Khaitov, N.I. Ilyina, T.V. Latysheva, L.V. Luss. Moscow: Literra, 2007. P. 24-31.
Review
For citations:
Emelyanov AV. Clinical use of H1-antihistamines. Meditsinskiy sovet = Medical Council. 2016;(4):74-81. (In Russ.) https://doi.org/10.21518/2079-701X-2016-4-74-81
Views:
927
Email this article 